Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1957 1
1966 2
1970 1
1981 2
1982 1
1983 1
1985 2
1986 3
1987 3
1988 4
1989 4
1990 5
1991 1
1992 1
1993 5
1994 3
1995 3
1996 3
1997 3
1998 2
1999 6
2000 3
2001 3
2002 5
2003 3
2004 8
2005 8
2006 9
2007 6
2008 7
2009 14
2010 13
2011 15
2012 17
2013 17
2014 22
2015 29
2016 19
2017 24
2018 33
2019 31
2020 34
2021 47
2022 42
2023 36
2024 11

Text availability

Article attribute

Article type

Publication date

Search Results

432 results

Results by year

Filters applied: . Clear all
Page 1
Showing results for compas
Your search for compaz retrieved no results
Vagus nerve stimulation for drug-resistant epilepsy.
Pérez-Carbonell L, Faulkner H, Higgins S, Koutroumanidis M, Leschziner G. Pérez-Carbonell L, et al. Pract Neurol. 2020 May;20(3):189-198. doi: 10.1136/practneurol-2019-002210. Epub 2019 Dec 31. Pract Neurol. 2020. PMID: 31892545 Review.
ComPAS: A Bayesian drug combination platform trial design with adaptive shrinkage.
Tang R, Shen J, Yuan Y. Tang R, et al. Stat Med. 2019 Mar 30;38(7):1120-1134. doi: 10.1002/sim.8026. Epub 2018 Nov 12. Stat Med. 2019. PMID: 30419609
To address this challenge, we propose a flexible Bayesian drug combination platform design with adaptive shrinkage (ComPAS), which allows for dropping futile combinations, graduating effective combinations, and adding new combinations during the course of the trial. ... …
To address this challenge, we propose a flexible Bayesian drug combination platform design with adaptive shrinkage (ComPAS), which al …
COMPAS-2: a dataset of cata-condensed hetero-polycyclic aromatic systems.
Mayo Yanes E, Chakraborty S, Gershoni-Poranne R. Mayo Yanes E, et al. Sci Data. 2024 Jan 19;11(1):97. doi: 10.1038/s41597-024-02927-8. Sci Data. 2024. PMID: 38242917 Free PMC article.
These new datasets represent the second installment in the COMputational database of Polycyclic Aromatic Systems (COMPAS) Project....
These new datasets represent the second installment in the COMputational database of Polycyclic Aromatic Systems (COMPAS) Project....
The COMPAS Project: A Computational Database of Polycyclic Aromatic Systems. Phase 1: cata-Condensed Polybenzenoid Hydrocarbons.
Wahab A, Pfuderer L, Paenurk E, Gershoni-Poranne R. Wahab A, et al. J Chem Inf Model. 2022 Aug 22;62(16):3704-3713. doi: 10.1021/acs.jcim.2c00503. Epub 2022 Jul 26. J Chem Inf Model. 2022. PMID: 35881922 Clinical Trial.
Chemical databases are an essential tool for data-driven investigation of structure-property relationships and for the design of novel functional compounds. We introduce the first phase of the COMPAS Projecta COMputational database of Polycyclic Aromatic Systems. ...
Chemical databases are an essential tool for data-driven investigation of structure-property relationships and for the design of novel funct …
Compas-Y: A mixed methods pilot evaluation of a mobile self-compassion training for people with newly diagnosed cancer.
Austin J, Schroevers MJ, Van Dijk J, Sanderman R, Børøsund E, Wymenga AMN, Bohlmeijer ET, Drossaert CHC. Austin J, et al. Digit Health. 2023 Oct 19;9:20552076231205272. doi: 10.1177/20552076231205272. eCollection 2023 Jan-Dec. Digit Health. 2023. PMID: 37868157 Free PMC article.
OBJECTIVE: Compas-Y is a compassionate mind training app that was co-designed to be fully adapted to mobile technology and to people with newly diagnosed cancer. ...RESULTS: About half of the participants (45%) used 4 of the 6 modules. Compas-Y was highly appreciate …
OBJECTIVE: Compas-Y is a compassionate mind training app that was co-designed to be fully adapted to mobile technology and to people …
Exploring the efficacy of dialectical behaviour therapy and methylphenidate on emotional comorbid symptoms in adults with attention Deficit/Hyperactivity disorder: Results of the COMPAS multicentre randomised controlled trial.
López-Pinar C, Selaskowski B, Braun N, Fornés-Ferrer V, Euscher R, Matthies S, Jans T, van Elst LT, Jacob C, Huss M, Sobanski E, Retz W, Roesler M, Retz-Junginger P, Alm B, Kis B, Abdel-Hamid M, Colla M, Berger M, Lux S, Philipsen A. López-Pinar C, et al. Psychiatry Res. 2023 Dec;330:115610. doi: 10.1016/j.psychres.2023.115610. Epub 2023 Nov 18. Psychiatry Res. 2023. PMID: 37992514 Clinical Trial.
The "ComPAS Trial" combined treatment model for acute malnutrition: study protocol for the economic evaluation.
Lelijveld N, Bailey J, Mayberry A, Trenouth L, N'Diaye DS, Haghparast-Bidgoli H, Puett C. Lelijveld N, et al. Trials. 2018 Apr 24;19(1):252. doi: 10.1186/s13063-018-2594-7. Trials. 2018. PMID: 29690899 Free PMC article.
METHOD: This is the protocol for the economic evaluation of the ComPAS trial, a cluster-randomised controlled, non-inferiority trial that compares a novel combined protocol for treating uncomplicated acute malnutrition compared to the current standard protocol in South Sud …
METHOD: This is the protocol for the economic evaluation of the ComPAS trial, a cluster-randomised controlled, non-inferiority trial …
Distress management.
Holland JC, Andersen B, Breitbart WS, Buchmann LO, Compas B, Deshields TL, Dudley MM, Fleishman S, Fulcher CD, Greenberg DB, Greiner CB, Handzo GF, Hoofring L, Hoover C, Jacobsen PB, Kvale E, Levy MH, Loscalzo MJ, McAllister-Black R, Mechanic KY, Palesh O, Pazar JP, Riba MB, Roper K, Valentine AD, Wagner LI, Zevon MA, McMillian NR, Freedman-Cass DA. Holland JC, et al. J Natl Compr Canc Netw. 2013 Feb 1;11(2):190-209. doi: 10.6004/jnccn.2013.0027. J Natl Compr Canc Netw. 2013. PMID: 23411386 Review.
Consolidated mathematical growth model of the primary tumor and secondary distant metastases of breast cancer (CoMPaS).
Tyuryumina EY, Neznanov AA. Tyuryumina EY, et al. PLoS One. 2018 Jul 6;13(7):e0200148. doi: 10.1371/journal.pone.0200148. eCollection 2018. PLoS One. 2018. PMID: 29979733 Free PMC article.
The CoMPaS is based on an exponential growth model and consists of a system of determinate nonlinear and linear equations and corresponds to the TNM classification. ...Additionally, the CoMPaS helps to consider the appearance and evolution period of secondary distan …
The CoMPaS is based on an exponential growth model and consists of a system of determinate nonlinear and linear equations and corresp …
432 results